Green tea treatment appears to reduce heart disease risk factors

 04/10/03 - A derivative of the green tea leaf may help reduce risk factors for heart disease, including bad cholesterol and high blood pressure, report researchers.

A study on Tegreen, a tea polyphenols product containing more than 65 per cent tea catechins, found that the product is capable of improving glucose and lipid metabolism in an obese rat model.

Researchers suggest that it could be used to treat Metabolic Syndrome X, the term used to describe a group of heart disease risk factors, including high levels of abdominal fat, bad cholesterol, high blood pressure, and abnormal glucose metabolism. Also known as Insulin Resistance Syndrome, the symptoms are thought to run in families with a history of type 2 diabetes. [NutraIngredients USA, Breaking News on Nutraceuticals and Supplements]

3:06:01 PM    

Pharmanex Joins the Council for Responsible Nutrition (CRN)

The Council for Responsible Nutrition (CRN), one of the dietary supplement industry's leading trade associations, recently welcomed four new member companies.  Joining CRN as voting members are Mannatech, Inc. of Coppell, Texas, and NuSkin/Pharmanex, LLC, of Provo, Utah. New associate members are the U.S. Pharmacopeia (USP), located in Rockville, Md., and Nutrition Business Journal (NBJ), based in San Diego, Calif.        
 
"We're pleased to welcome these four companies to CRN and appreciate their commitment to work with us to rebuild consumer confidence in the quality, safety, and effectiveness of dietary supplements," said Annette Dickinson, Ph.D., president, CRN. "The CRN staff looks forward to teaming with representatives from these companies in efforts that will strengthen and build our industry."
 
Pharmanex, a NuSkin Enterprises' company, is a leader in the research and development of phyto-pharmaceutical and nutritional products, highly committed to accomplishing its mission: to help people live healthy and productive lives. [Council for Responsible Nutrition]

2:59:00 PM